Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes
about
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityProtease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sitesHuman dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesCharacterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c miceEffect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitroDevelopment and use of SIV-based Integrase defective lentiviral vector for immunization.Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes.Ramifications of HLA class I polymorphism and population genetics for vaccine development.
P2860
Q28749845-E92B19C7-34D5-4E7E-AE9D-EDA851A1AC37Q33614461-CE44ED17-5EC0-40AF-9261-8A34EEEF0D87Q33782430-1E91D0E5-60E8-4009-B37A-329967210022Q33786140-A61C46D5-05B4-41BC-8D3B-C986517CE412Q33842771-DEC390FB-9222-416C-B75C-149D42BE7D56Q34592940-0FC0F4C6-D6DB-445A-8821-496B976F218AQ34999946-C9D8F83D-7015-4B1F-A1AD-AE9567610975Q36283522-182DCAE4-123D-4D6E-A099-3E72E13C57C2Q36315529-12727E39-0974-4DDB-90E5-28202A6331E3Q36433369-57E0F190-6D0C-4B00-80D9-4624C3E2AF28Q37369322-5B12C758-F94E-43F8-8CD6-F6AEA8ABC54CQ39787669-0E1EDA42-8B16-48DC-B2F4-1B5354D072EDQ52070060-0BC529A0-D62E-4EAD-BA56-95435422BBAF
P2860
Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@ast
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@en
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@nl
type
label
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@ast
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@en
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@nl
prefLabel
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@ast
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@en
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@nl
P2093
P356
P1476
Molecular analysis of presenta ...... human cytotoxic T lymphocytes
@en
P2093
C D Pendleton
J A Berzofsky
J E Coligan
K C Parker
M A Alexander-Miller
P356
10.1093/INTIMM/8.5.641
P407
P577
1996-05-01T00:00:00Z